NO20010946L - Karbamat og ureasammensetninger og nevrotrofiske anvendelser - Google Patents

Karbamat og ureasammensetninger og nevrotrofiske anvendelser

Info

Publication number
NO20010946L
NO20010946L NO20010946A NO20010946A NO20010946L NO 20010946 L NO20010946 L NO 20010946L NO 20010946 A NO20010946 A NO 20010946A NO 20010946 A NO20010946 A NO 20010946A NO 20010946 L NO20010946 L NO 20010946L
Authority
NO
Norway
Prior art keywords
neurotrophic
carbamate
applications
urea compositions
compositions
Prior art date
Application number
NO20010946A
Other languages
English (en)
Other versions
NO20010946D0 (no
Inventor
Jia-He Li
Joseph P Steiner
Gregory S Hamilton
Original Assignee
Guilford Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharm Inc filed Critical Guilford Pharm Inc
Publication of NO20010946L publication Critical patent/NO20010946L/no
Publication of NO20010946D0 publication Critical patent/NO20010946D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Foreliggende oppfinnelse omhandler farmasøytiske sammensetninger og fremgangsmåter for å fremkalle en nerveaktivitet ved å benytte lavmolekylvekt, små molekyl karbamater og ureaer som har affinitet for FKBP-type immunofiliner.
NO20010946A 1998-08-25 2001-02-23 Karbamat og ureasammensetninger og nevrotrofiske anvendelser NO20010946D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/139,672 US6242468B1 (en) 1997-02-27 1998-08-25 Carbamate and urea compositions and neurotrophic uses
PCT/US1999/019261 WO2000010553A2 (en) 1998-08-25 1999-08-24 Carbamate and urea compositions and neurotrophic uses

Publications (2)

Publication Number Publication Date
NO20010946L true NO20010946L (no) 2001-02-23
NO20010946D0 NO20010946D0 (no) 2001-02-23

Family

ID=22487769

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20010946A NO20010946D0 (no) 1998-08-25 2001-02-23 Karbamat og ureasammensetninger og nevrotrofiske anvendelser

Country Status (18)

Country Link
US (1) US6242468B1 (no)
EP (1) EP1107757A2 (no)
JP (1) JP2002523367A (no)
KR (1) KR20010072992A (no)
CN (1) CN1313767A (no)
AU (1) AU5687999A (no)
BG (1) BG105340A (no)
BR (1) BR9912988A (no)
CA (1) CA2341530A1 (no)
CZ (1) CZ2001274A3 (no)
EA (1) EA200100271A1 (no)
HU (1) HUP0103166A3 (no)
IL (1) IL140958A0 (no)
MX (1) MXPA01001937A (no)
NO (1) NO20010946D0 (no)
PL (1) PL346759A1 (no)
SK (1) SK2562001A3 (no)
WO (1) WO2000010553A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7008960B1 (en) 1999-03-02 2006-03-07 Vitreo-Retinal Technologies, Inc. Agents for intravitreal administration to treat or prevent disorders of the eye
EP1196386A2 (en) * 1999-07-06 2002-04-17 Vertex Pharmaceuticals Incorporated N-substituted glycine derivatives
US20030199574A1 (en) 2000-03-02 2003-10-23 Vitreo-Retinal Technologies, Inc. Treatment of ophthalmic disorders using urea and urea derivatives
US7977385B2 (en) * 2000-03-02 2011-07-12 Numoda Biotechnologies, Inc. Agents for corneal or intrastromal administration to treat or prevent disorders of the eye
US20050137124A1 (en) * 2002-08-09 2005-06-23 Vitreo-Retinal Technologies, Inc. A California Corporation Agents for intravitreal administration to treat or prevent disorders of the eye
EP1402888A1 (en) * 2002-09-18 2004-03-31 Jerini AG The use of substituted carbocyclic compounds as rotamases inhibitors
CA2556622A1 (en) 2004-03-02 2005-09-15 Wyeth Macrolides and methods for producing same
US20050197356A1 (en) * 2004-03-02 2005-09-08 Wyeth Non-immunosuppressive immunophilin ligands as neuroprotective and/or neuroregenerative agents
WO2007061554A2 (en) * 2005-10-21 2007-05-31 Purdue Research Foundation Dosage of 4-aminopyridine derivatives for treatment of central nervous system injuries
EP2797880B1 (en) * 2011-12-27 2017-03-01 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI874163A7 (fi) 1986-09-26 1988-03-27 Mitsui Toatsu Chemicals Incorporated Katekolijohdannaiset sekä niitä sisältävät keskushermoston taantumasairauksia ehkäisevät ja parantavat valmisteet.
US5214034A (en) 1986-09-26 1993-05-25 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system containing the same
IT1206078B (it) 1987-06-03 1989-04-14 Polifarma Spa Procedimento per la produzione di acido 3-indolpiruvico e suoi derivati loro uso farmaceutico
US5232923A (en) 1988-03-18 1993-08-03 Mitsui Toatsu Chemicals, Incorporated Catechol derivatives and pharmaceutical preparations containing same
US5166317A (en) 1988-10-31 1992-11-24 Houston Biotechnology Incorporated Neurotrophic factor
US5215969A (en) 1989-08-11 1993-06-01 Hahnemann University Dopaminergic neurotrophic factor for treatment of Parkinson's disease
US5620971A (en) 1991-05-09 1997-04-15 Vertex Pharmaceuticals Incorporated Biologically active acylated amino acid derivatives
US5744485A (en) 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
IL115685A (en) * 1994-11-16 2000-08-31 Vertex Pharma Amino acid derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
US6037370A (en) 1995-06-08 2000-03-14 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5717092A (en) 1996-03-29 1998-02-10 Vertex Pharmaceuticals Inc. Compounds with improved multi-drug resistance activity
US5840736A (en) 1996-11-13 1998-11-24 Vertex Pharmaceuticals Incorporated Methods and compositions for stimulating neurite growth
US5780484A (en) 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5811434A (en) 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
US5935989A (en) * 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
ZA98825B (en) * 1997-02-27 1998-10-19 Guilford Pharm Inc Method of using neurotrophic carbamates and ureas

Also Published As

Publication number Publication date
IL140958A0 (en) 2002-02-10
JP2002523367A (ja) 2002-07-30
CZ2001274A3 (cs) 2001-09-12
EP1107757A2 (en) 2001-06-20
CN1313767A (zh) 2001-09-19
EA200100271A1 (ru) 2001-10-22
KR20010072992A (ko) 2001-07-31
AU5687999A (en) 2000-03-14
MXPA01001937A (es) 2002-04-24
SK2562001A3 (en) 2001-09-11
NO20010946D0 (no) 2001-02-23
BR9912988A (pt) 2001-10-02
HUP0103166A2 (hu) 2002-05-29
WO2000010553A2 (en) 2000-03-02
WO2000010553A3 (en) 2000-05-18
BG105340A (en) 2001-12-29
US6242468B1 (en) 2001-06-05
PL346759A1 (en) 2002-02-25
CA2341530A1 (en) 2000-03-02
HUP0103166A3 (en) 2002-10-28

Similar Documents

Publication Publication Date Title
WO2004110352A3 (en) Compounds having activity in increasing ion transport by mutant-cftr and uses thereof
NO20010946L (no) Karbamat og ureasammensetninger og nevrotrofiske anvendelser
BR0111878A (pt) N-ureido-(heterociclo-alquil)-piperidinas como moduladores da atividade de receptores de quimiocinas
NO20060719L (no) Substituerte cykloalkylaminderivater som modulatorer av kemokin reseptor aktivitet
NO20013003L (no) Kinolin-derivater
ATE231145T1 (de) Nichtpeptidische tachykinin-rezeptor-antagonisten
EA200601555A1 (ru) Замещенные индазол-о-глюкозиды
NO20005224L (no) BTK inhibitorer og fremgangsmåter for deres identifikasjon og anvendelse
MX9804011A (es) Inhibidores de la actividad rotamasa de ciclofilina.
MXPA03006666A (es) Compuestos de union de ciclofilina carbociclicos trisubstituidos y su uso.
NO991433L (no) Heterosykliske estere og amider
WO2003041641A3 (en) Tetrahydroisoquinoline analogs as modulators of chemokine receptor activity
NO20012977L (no) N-ureidoalkylpiperidiner som modulatorer av chemokinreseptoraktivitet
ID18883A (id) Pesaing 5-ht 1f
DE60131730D1 (de) Agonisten und antagonisten für den lpa-rezeptor und anwendungsmethoden
MXPA99006120A (es) Sulfonamidas n-enlazadas de tioesteres heterociclicos.
ATE302606T1 (de) N-ureidoalkylpiperidine als modulatoren der aktivität der chemokinrezeptoren
WO2002072536A8 (en) Urea derivatives having vanilloid receptor (vr1) antagonist activity
DK1675591T3 (da) Farmaceutisk sammensætning omfattende en monoamin-neurotransmitter-genoptagelseshæmmer og en acetylcholinesterase-hæmmer
TW200612945A (en) Aerosol suspension formulations containing TG 227 ea as propellant
WO2001028987A8 (en) Benzylcycloalkyl amines as modulators of chemokine receptor activity
WO2005090296A3 (en) N-substituted benzene sulfonamides
NO20023643L (no) Forbindelser som har antitumoraktivitet, fremgangsmåte for deres fremstilling og farmasöytiske sammensetninger som inneholderdem
ATE479657T1 (de) N-(aryl)-2-arylethensulfonamide und ihre therapeutischen anwendungen
WO2001004116A3 (en) Neurotrophic pyrrolidines and piperidines, and related compositions containing them

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application